Jump to content
Sorbact Technology

Bacteria can’t resist Sorbact
– it’s the law of nature

Based on a purely physical mode of action, Sorbact safely removes bacteria to prevent and treat wound infection without releasing active agents into the wound.

The power of safe wound infection management

Sorbact Technology effectively prevents and treats wound infection across all ages, from sensitive children to elderly. Developed with a physical mode of action, bacteria irreversibly bind to the DACC™-coated surface and are safely removed. Evidence presents an antibacterial effect without the release of active substances, and therefore antimicrobial resistance is not expected. Sorbact Technology dressings deliver powerful, safe and effective wound infection management for the advancement of patient well-being.

Sorbact Technology logo placed on top of a close-up of a Sorbact dressing.

Bind

  • The DACC™-coated surface of Sorbact has special characteristics and hydrophobic properties
  • Bacteria naturally bind and anchor to the unique Sorbact surface
  • Also binds endotoxins that may impair wound healing*

*In vitro data

Inhibit

  • Bacteria are irreversibly bound and growth is inhibited
  • Endotoxins are shown not to be released from the bacteria*
  • Antimicrobial resistance is not expected

*In vitro data

Remove

  • Bound bacteria, fungi and endotoxins are safely removed
  • The bacterial load in the wound bed is reduced
  • Reduced bioburden supports natural wound healing

Watch and learn how Sorbact Technology works

Sorbact advantages

No known antimicrobial resistance

Sorbact is not only highly effective against common wound bacteria including MRSA and VRE[6]View reference information but also targets fungi. With the Sorbact Technology mode of action, unlike certain antimicrobial substances that kill microbes, development of bacterial or fungal resistance is not expected, and it can be used for a prolonged period of time.

Read more

References

  1. Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24:121-127.

    External link to reference1 (Opens in new tab) Back

  2. Ciliberti M et al. The effect of a bacteria- and fungi-binding mesh dressing on the bacterial load of pressure ulcers treated with negative pressure wound therapy: A pilot study. Wounds. 2016;28:408-420.

    External link to reference2 (Opens in new tab) Back

  3. Susilo YB et al. Significant and rapid reduction of free endotoxin using a dialkylcarbamoyl chloride-coated wound dressing. J Wound Care. 2022;31:502-509.

    Back

  4. Susilo YB et al. Significant and rapid reduction of free endotoxin using a dialkylcarbamoyl chloride-coated wound dressing. J Wound Care. 2022;31:502-509.

    Back

  5. Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.

    External link to reference5 (Opens in new tab) Back

  6. Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022;31:560-570.

    External link to reference6 (Opens in new tab) Back